COLIPA validation project on in vitro eye irritation tests for cosmetic ingredients and finished products (Phase I):: The red blood cell test for the estimation of acute eye irritation potentials.: Present status

被引:35
作者
Pape, WJW
Pfannenbecker, U
Argembeaux, H
Bracher, M
Esdaile, DJ
Hagino, S
Kasai, Y
Lewis, RW
机构
[1] Beiersdorf AG, Lead Lab, D-20245 Hamburg, Germany
[2] H Schwarzkopf GmbH, D-22763 Hamburg, Germany
[3] Wella Cosmital SA, CH-1723 Marly, Switzerland
[4] RhonePoulenc, F-06903 Sophia Antipolis, France
[5] Shiseido Safety & Analyt Res Ctr, Kohoku Ku, Yokohama, Kanagawa 223, Japan
[6] Kao Corp, Tochigi Biol Sci Lab, Ichikaimachi Haga, Tochigi 32134, Japan
[7] Zeneca Cent Toxicol Lab, Macclesfield SK10 4TJ, Cheshire, England
关键词
validation; red blood cell test; in vitro alternative; eye irritation potential; haemolysis; haemoglobin denaturation; cosmetic products; cosmetic ingredients; prediction models;
D O I
10.1016/S0887-2333(98)00085-X
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 [卫生毒理学];
摘要
The red blood cell test (RBC test) is part of the COLIPA Validation Project on Alternatives to Draize Eye Irritation. It shows good intra- and interlaboratory reproducibility (reliability) and represents one of the promising in vitro alternatives of this project with a good fit to prediction models (relevance) for the assessment of acute ocular irritancy caused by certain classes of chemicals (mainly surfactants) and formulations. Results obtained during the period of test development, prevalidation, and validation are summarized. The method is based on that of Pape er al. (1987), Pape and Hoppe (1990) and Lewis et ai. (1993). The protocol has two endpoints: cellular lysis and changes in protein conformation which can be correlated with initial events in tissue injury inducing inflammatory responses as assessed by Draize eye irritation scoring. Both endpoints are detected by spectrophotometric changes in the haemoglobin absorption at 541 nm. The protocol also includes a set of prediction models (PM). One PM is designed to predict three classes of irritancy (classification model) based on both endpoints and the three other PMs are designed to predict modified maximum average scores (MMAS) by algorithms based on data from cellular lysis only. These three PMs [with prediction intervals (PIs)] are: (i) far surfactant ingredients, (ii) for surfactant containing finished products, and (iii) for both groups together. The three PMs are based on a common algorithm derived from historic data. It is shown that PMs derived from historic data from several laboratories, by the same procedure, also produce a good fit with the presented data. Therefore, participating laboratories concluded that the protocol as used in this formal validation study can be considered to be validated for the estimation of acute eye irritation potential of surfactant-containing finished products. (C) 1999 Elsevier Science Ltd. All lights reserved.
引用
收藏
页码:343 / 354
页数:12
相关论文
共 25 条
[1]
PROTEIN DENATURATION AND THE PROPERTIES OF PROTEIN GROUPS [J].
ANSON, ML .
ADVANCES IN PROTEIN CHEMISTRY, 1945, 2 :361-386
[2]
EYE IRRITATION - REFERENCE CHEMICALS DATA-BANK [J].
BAGLEY, DM ;
BOTHAM, PA ;
GARDNER, JR ;
HOLLAND, G ;
KREILING, R ;
LEWIS, RW ;
STRINGER, DA ;
WALKER, AP .
TOXICOLOGY IN VITRO, 1992, 6 (06) :487-491
[3]
The EC/HO international validation study on alternatives to the Draize eye irritation test [J].
Balls, M ;
Botham, PA ;
Bruner, LH ;
Spielmann, H .
TOXICOLOGY IN VITRO, 1995, 9 (06) :871-929
[4]
TOXICITY DETERMINED INVITRO BY MORPHOLOGICAL ALTERATIONS AND NEUTRAL RED ABSORPTION [J].
BORENFREUND, E ;
PUERNER, JA .
TOXICOLOGY LETTERS, 1985, 24 (2-3) :119-124
[5]
A summary report of the COLIPA international validation study on alternatives to the Draize rabbit eye irritation test [J].
Brantom, PG ;
Bruner, LH ;
Chamberlain, M ;
DeSilva, O ;
Dupuis, J ;
Earl, LK ;
Lovell, DP ;
Pape, WJW ;
Uttley, M ;
Bagley, DM ;
Baker, FW ;
Bracher, M ;
Courtellemont, P ;
Declercq, I ;
Freeman, S ;
Steiling, W ;
Walker, AP ;
Carr, GJ ;
Dami, N ;
Thomas, G ;
Harbell, J ;
Jones, PA ;
Pfannenbecker, U ;
Southee, JA ;
Tcheng, M ;
Argembeaux, H ;
Castelli, D ;
Clothier, R ;
Esdaile, DJ ;
Itigaki, H ;
Jung, K ;
Kasai, Y ;
Kojima, H ;
Kristen, U ;
Larnicol, M ;
Lewis, RW ;
Marenus, K ;
Moreno, O ;
Peterson, A ;
Rasmussen, ES ;
Robles, C ;
Stern, M .
TOXICOLOGY IN VITRO, 1997, 11 (1-2) :141-179
[6]
ECETOC, 1992, 48 ECETOC
[7]
The CFTA evaluation of alternatives program: An evaluation of in vitro alternatives to the Draize primary eye irritation test. (Phase III) surfactant-based formulations [J].
Gettings, SD ;
Lordo, RA ;
Hintze, KL ;
Bagley, DM ;
Casterton, PL ;
Chudkowski, M ;
Curren, RD ;
Demetrulias, JL ;
Dipasquale, LC ;
Earl, LK ;
Feder, PI ;
Galli, CL ;
Glaza, SM ;
Gordon, VC ;
Janus, J ;
Kurtz, PJ ;
Marenus, KD ;
Moral, J ;
Pape, WJW ;
Renskers, KJ ;
Rheins, LA ;
Roddy, MT ;
Rozen, MG ;
Tedeschi, JP ;
Zyracki, J .
FOOD AND CHEMICAL TOXICOLOGY, 1996, 34 (01) :79-117
[8]
TOXICOLOGICAL PROPERTIES OF SURFACTANTS [J].
GLOXHUBER, C .
ARCHIVES OF TOXICOLOGY, 1974, 32 (04) :245-269
[9]
SOLUBILIZATION OF MEMBRANES BY DETERGENTS [J].
HELENIUS, A ;
SIMONS, K .
BIOCHIMICA ET BIOPHYSICA ACTA, 1975, 415 (01) :29-79
[10]
HEMOLYSIS BY NONIONIC SURFACE-ACTIVE AGENTS [J].
KONDO, T ;
TOMIZAWA, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1968, 57 (07) :1246-&